Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Ho: Ibalizumab for HIV Prevention |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2009-12-28 |
| Study Made Public: | NA |
Title
In Vivo Activity of Ibalizumab Administered by Subcutaneous Injection
Description
CAVD 310 is a non-human primate study comparing administration of the monoclonal antibody, Ibalizumab, via intravenous and subcutaneous routes.
Sign in to see full information about this study and to download study data.
Products
IbalizumabIntegrated data
NAb, NAb MAb
Non-integrated data
No non-integrated data is available for this study.